Total Payments
$11,773
2024 Payments
$1,791
Companies
42
Transactions
703
Medicare Patients
7,148
Medicare Billing
$457,211
Payment Breakdown by Category
Food & Beverage$11,409 (96.9%)
Education$363.61 (3.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,409 | 678 | 96.9% |
| Education | $363.61 | 25 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,464 | 141 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,980 | 119 | $0 (2024) |
| Janssen Biotech, Inc. | $703.54 | 56 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $592.24 | 30 | $0 (2024) |
| Galderma Laboratories, L.P. | $554.69 | 40 | $0 (2024) |
| Amgen Inc. | $493.28 | 29 | $0 (2024) |
| LEO Pharma Inc. | $454.75 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $416.42 | 26 | $0 (2024) |
| PFIZER INC. | $399.34 | 26 | $0 (2024) |
| Lilly USA, LLC | $361.28 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,791 | 87 | ABBVIE INC. ($541.64) |
| 2023 | $1,263 | 69 | ABBVIE INC. ($292.50) |
| 2022 | $1,770 | 103 | ABBVIE INC. ($584.96) |
| 2021 | $1,635 | 104 | AbbVie Inc. ($358.10) |
| 2020 | $872.39 | 56 | Novartis Pharmaceuticals Corporation ($237.67) |
| 2019 | $1,373 | 81 | AbbVie, Inc. ($374.76) |
| 2018 | $1,506 | 117 | Taro Pharmaceuticals USA, Inc. ($313.33) |
| 2017 | $1,564 | 86 | Novartis Pharmaceuticals Corporation ($488.77) |
All Payment Transactions
703 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.10 | General |
| Category: Immunology | ||||||
| 12/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.10 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.25 | General |
| Category: Immunology | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.68 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $11.70 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.16 | General |
| Category: Immunology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.48 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.12 | General |
| Category: Immunology | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.65 | General |
| Category: Immunology | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $29.88 | General |
| Category: Dermatology | ||||||
| 09/25/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,935 | 3,993 | $271,870 | $128,725 |
| 2022 | 14 | 1,739 | 3,510 | $241,391 | $113,086 |
| 2021 | 14 | 1,761 | 3,357 | $245,169 | $115,100 |
| 2020 | 16 | 1,713 | 3,269 | $214,588 | $100,300 |
Total Patients
7,148
Total Services
14,129
Medicare Billing
$457,211
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 416 | 632 | $72,154 | $35,282 | 48.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 312 | 398 | $49,999 | $21,981 | 44.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 205 | 253 | $35,507 | $18,426 | 51.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 322 | 454 | $37,985 | $13,231 | 34.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 260 | 1,709 | $14,102 | $7,897 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 85 | $13,771 | $6,915 | 50.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 46 | 56 | $11,765 | $6,161 | 52.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 109 | 161 | $10,060 | $5,716 | 56.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 23 | $5,125 | $3,011 | 58.7% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 31 | 37 | $6,090 | $2,929 | 48.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 56 | 62 | $4,402 | $2,238 | 50.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $4,675 | $2,155 | 46.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 15 | 17 | $3,135 | $1,581 | 50.4% |
| 69100 | Biopsy of ear | Office | 2023 | 15 | 17 | $2,041 | $837.91 | 41.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 13 | 14 | $997.22 | $336.83 | 33.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 42 | $61.20 | $28.10 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 410 | 591 | $69,336 | $33,827 | 48.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 285 | 354 | $46,055 | $20,415 | 44.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 154 | 180 | $25,848 | $13,297 | 51.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 301 | 421 | $36,147 | $12,748 | 35.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 251 | 1,511 | $12,859 | $7,204 | 56.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 43 | 55 | $11,813 | $6,476 | 54.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 108 | 170 | $11,069 | $6,095 | 55.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 60 | $9,949 | $4,658 | 46.8% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2022 | 19 | 25 | $4,217 | $2,192 | 52.0% |
About Dr. Catherine Lucas, MD
Dr. Catherine Lucas, MD is a Dermatology healthcare provider based in Northport, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841240363.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Lucas, MD has received a total of $11,773 in payments from pharmaceutical and medical device companies, with $1,791 received in 2024. These payments were reported across 703 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($11,409).
As a Medicare-enrolled provider, Lucas has provided services to 7,148 Medicare beneficiaries, totaling 14,129 services with total Medicare billing of $457,211. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Northport, AL
- Active Since 05/12/2006
- Last Updated 02/23/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1841240363
Products in Payments
- COSENTYX (Biological) $1,596
- SKYRIZI (Biological) $983.29
- RINVOQ (Biological) $861.59
- DUPIXENT (Biological) $644.21
- Humira (Biological) $540.07
- Sotyktu (Drug) $416.42
- EUCRISA (Drug) $382.58
- TALTZ (Drug) $361.28
- Otezla (Drug) $312.90
- TREMFYA (Drug) $303.58
- DAXXIFY (Drug) $270.98
- EPIDUO FORTE (Drug) $230.27
- ADBRY (Biological) $221.65
- REMICADE (Biological) $200.20
- COSENTYX (Drug) $194.67
- ENSTILAR (Drug) $186.83
- Zoryve (Drug) $166.66
- Enbrel (Biological) $164.13
- DUPIXENT DUPILUMAB INJECTION (Biological) $150.03
- STELARA (Biological) $143.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Northport
Dr. Jeffery Weeks, Md, MD
Dermatology — Payments: $15,948
Dermatology $15,948
Dr. Karen Walker, M.d, M.D
Dermatology — Payments: $9,998
Dermatology $9,998
Dr. Adam Richardson, Do, Faad, DO, FAAD
Dermatology — Payments: $7,542
Dermatology $7,542
Dr. Charles Gambla, Md, MD
Dermatology — Payments: $5,828
Dermatology $5,828
Mrs. Alicia Nichols, Crnp, CRNP
Dermatology — Payments: $5,385
Dermatology $5,385
Dr. David Jackson, Md, MD
Dermatology — Payments: $2,967
Dermatology $2,967